Trial reportClinical and experimental dental research2025
Polycaprolactone Impregnated 3D Printed Nanohydroxyapatite for Sinus Augmentation: A Randomized Controlled Trial.
Trial report in Clinical and experimental dental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Polycaprolactone Impregnated 3D Printed Nanohydroxyapatite for Sinus Augmentation: A Randomized Controlled Trial.Clinical and experimental dental research · 2025Trial
- Research hotspots and emerging trends of 3D printing in bone defects: a bibliometric analysis based on Web of Science core collection from 2006 to March 2026.Cell and tissue banking · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo compare the effect of polycaprolactone impregnated 3D printed nano-hydroxyapatite (3DPHA-PCL) with bovine bone substitute material (BB) in lateral maxillary sinus floor elevation (MSFE). MATERIALS AND
methodsLateral MSFE with two bone substitute materials was randomly performed in two centers: group BB (n = 11 sinuses) or group 3DPHA-PCL (n = 11 sinuses). Lateral MSFE with two bone substitute materials was performed on 21 participants across two centers, resulting in a total of 22 sinuses analyzed. The sinuses were randomly allocated into two groups: group BB (11 sinuses) and group 3DPHA-PCL (11 sinuses). Cone beam computed tomography (CBCT) was taken before (T0) and immediately after MSFE (T1), at 6 months (implant placement; T2), and 1 year (T3). Dimensional stability of the augmentation was analyzed using serial CBCT scans. At the time of implant placement, bone core biopsy was performed, followed by microcomputed tomographic (micro-CT) and histomorphometric analyses.
resultsBased on the superimposed CBCT images between T1 and T2, the augmented height and volume decreased in both groups without a statistically significant difference between the groups (-0.48 ± 1.01 mm, -53.9 ± 117.8 mm
conclusionsDimensional stability of the augmented bone was comparable between the groups. However, group 3DPHA-PCL demonstrated inferior new bone formation and implant survival compared to group BB. Long-term follow-up is warranted to monitor the behavior of 3DPHA-PCL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.